Introduction
Actually, these impressive nanoscale molecules were found almost 40 years ago at the same time by two different research groups (Stahl et al. and Johnstone et al.) when investigating the transferrin receptors in reticulocytes. These tiny molecules, which have been ignored as cellular waste for years, have been recognized to have a scientific importance beyond time; the societies were established (International Society for Extracellular Vesicles and The American Society for Exosomes and Microvesicles), dedicated journal was published (Journal of Extracellular Vesicles) [1] [2] [3] . Insomuch that there is a database named ExoCarta and even they have been included in the Nobel Physiology and Medicine Award in 2013. Probably they are the child genius of biomolecules…
Exosomes: Smart Munchkins
Exosomes are simply defined as Extracellular Vesicles (EVs) released from cells. They are lipid-encapsulated and transmit molecular markers such as proteins and nucleic acids between the cells to alter the phenotype of the recipient cells [1, 4] . The term exosome was first reported in 1981 by Trams et al. and used to identify exfoliated microvesicles derived from membrane with 5'-nucleotidase activity [5, 6] .
In fact, EVs are divided into four classes according to the formation and size of the cells. These are microvesicles released directly from the cell membrane to the outside of the cell, apoptosomes resulting from apoptosis, retrovirus-like vesicles, and exosomes that occur indirectly through the cell membrane [7] .
Exosomes have been studied in many investigations and are called as; a) Vexosome (microvesicles/exosomes that are associated with adeno-associated virus vectors) [8] , b) Oncosomes (tumor-derived microvesicles that transfer oncogenic signals and protein complexes across cell boundaries) [9] , c)
Prostasomes (exosomes originating from the epithelial cells of the prostate and prostatic fluid) [10] , d) Dexosomes (exosomes derived from dendritic cells) [11] , e) Cardiosome (microvesicles/exosomes from cardiomyocytes) [8] , f)
Texosomes (exosomes derived from tumors) [12] , g) Epididymosome (found in the intraluminal epididymal compartment) [13] , h) Argozome (exosome-like bodies in drosophila) [14] , i)
Archeosome (liposome from polar lipids of Archaea) [15] according to the cell type they originate from [7, 16] .
Exosome function varies depending on the type of cell they are derived from and the composition of the exosomes [17] . Initial investigations suggested that exosomes were only involved in removing waste from the cell. But recent studies have shown that vesicular content of exosomes includes distinct molecular and genetic components such as nucleic acids, proteins, miRNAs, mRNAs, nucleoproteins, mitochondrial DNA, Single-Stranded DNA (ssDNA) and Double-Stranded DNA (dsDNA), soluble factors and various enzymes to be used for important roles such as intercellular communication, signal transduction, as opposed to cargo contents not only consisting of waste molecules [18, 19] . Exosomes are found in vivo in many biological fluids including blood, urine, saliva, epididymal fluid, amniotic liquid, bronchoalveolar lavage, synovial fluid and breast milk [20] [21] [22] [23] . e) Exosomes are also released from cardiomyocytes and are required for normal functioning of the cardiovascular system [2] .
The Role of Exosomes in Cancer
Exosomes affect tumor progression, metastasis and therapeutic efficacy due to cell-cell communication [27] . Therefore, exosomes in cancer have often been described as promoters of tumor progression. But it is conceivable that the exosomes also have antitumor functions and may act to limit disease progression [28] . Exosomes are also secreted by cancer cells and tumor-associated stromal cells, but they are adapted in cancer processes and serve as a pathway for neoplastic cells to communicate with each other (autocrine) and non-neoplastic cells (paracrine and endocrine) [29] .
Exosomes have important role in many malignant processes such as cancer progression, metastasis and drug resistance in cancer; a) Malignant cells secrete about 10 times more exosomes than the normal cells [30] . b) They can inhibit immune response through transferring their genetic information to the recipient cells [30] .
c)
They cause invasion and metastasis by carrying cargo contents into cells in the tumor microenvironment [31] . d) They promote metastasis by promoting epithelial mesenchymal transformation [32] . e) They stimulate cell proliferation by transmitting mitogenic signals to tumor environment.
f)
They suppress the immune system cells (macrophages, natural killer cells) or deliver apoptotic signals to these cells g) In addition, they cause drug resistance and resistance to chemotherapy by activating multi-drug-resistant proteins.
Exosomes in Metastasis
Exosomes are known mobile elements that function as escape routes for proteins and miRNAs (some of these miRNAs may be promoters of metastatic pathways) from distant locations in a cell. As expected, the role of exosome-mediated signaling in cancer metastasis is also evident. For example, Grange and colleagues have shown that exosomes released from kidney cells develop angiogenesis in lung cancer assays [33] .
Cancer cells can metastasize through blood circulation or lymphatic pathways. For metastasis, cells must invade systemic circulation or lymphatic circulation by invading the extracellular matrix. Metastasis is a very active process, involving cancer cells as well as microenvironment, cytokines, stromal cells, and immunocyte cells. Epithelial-mesenchymal transformation is necessary for cells to acquire metastatic properties [32] .
EMT (epithelial mesenchymal transition) is defined as losing epithelial properties of cells and acquiring mesenchymal properties and directed by a complex network of interactions. At this point, the cells gain the ability to invasion and migration and considered to be one of the distinguishing features of aggressive tumors. EMTpassing cells have improved plasticity and tendency to migrate from the origin zone, which causes tumor spread. EMT type cells secrete factors that act on neighboring cells and tissues and contribute to resistance by protecting the tumoral microenvironment. The role of exosomes in EMT has recently been determined [6, 34] .
In addition, exosomes can promote the invasion and metastasis by directly targeting tight and adherens junctions. For instance, the increased vascular permeability, lung and brain metastases were observed when the expression of the tight junction protein ZO-1 downregulated by exosomal miR-105 in endothelial monolayer cells [35] .
Exosomes and Angiogenesis
The process of angiogenesis is the occurrence of new vessel formation from the existing vessels. This process is controlled by multiple growth factors, signaling pathways pro-angiogenic and antiangiogenic factors. In addition, recent studies have shown that angiogenesis can also be regulated by cell-derived microparticles such as micro-vesicules and exosomes [36] .
The growth of new vessels at the beginning of tumor development is related to the exosome levels produced by the tumor. For example, glioblastomas produce tumor-derived exosomes that affect the proliferation of endothelial cells and are highly vascularized compared to other solid tumors. Extracellular vesicles secreted by glioblastomas contain angiogenic proteins and have pro-angiogenic properties in vitro and in vivo [37] . Rapid proliferation of solid tumors causes hypoxic and necrotic areas in tissues. Endothelial proliferation and angiogenesis are induced by pro-angiogenic factors in the tumor stroma, as more oxygen, nutrition and removal of cellular waste products are needed, in the case of hypoxia. Studies have shown that exosomal secretion increases in hypoxic conditions in multiple myeloma and breast cancer cells [38] .
Exosomes in Lung Cancer
Lung cancer is the leading cause of cancer-related death between men and women, and approximately 70% of patients with lung cancer are found with symptoms that are locally advanced or cause metastatic disease, which is not appropriate for treatment [39] . The exosomes are the components contributing to metastasis as mentioned earlier. A studies have been conducted on the role of exosomes in a cancer type in which metastasis is common, such as lung cancer [24, 40, 41] . These studies also show that exosomal miRNAs can be used as diagnostic markers for lung cancer [41] ( Figure 1 ). Tumor-derived exosomes were initially demonstrated in the peripheral circulation of cancer patients in 1979 [42] . Tumorderived exosomes overexpose a number of common tumor proteins, as well as a number of tumor antigens that reflect tumor cells. These exosomes also mediate tumor growth, metastasis, drug resistance, and facilitating immunosuppression. Although exosomal release can be demonstrated in many proliferating cell types, their proliferation increases in tumor cells, as evidenced by their increased presence in the plasma and pleural effusions of cancer patients [43, 44] .
Tumor-derived exosomes mediate tumorigenesis by facilitating tumor growth, metastasis, drug resistance and immunosuppression. Peinodo et al. showed that melanoma-derived exosomes increased endothelial permeability in mice and increased lung metastases [45] . Very few studies in lung cancer have characterized exosomes and their role in lung cancer progression. Recent experimental studies have emphasized that exosomes can activate target cells by ligand-receptor interaction and fusion of recipient cells with plasma membrane [45] [46] [47] [48] [49] . Furthermore, endocytosis of exomes and subsequent transfer of molecules directly to the cytosol of the recipient cell can functionally suppress target genes in recipient cells [50] . Vimentin, as a part of exosomal content, has been shown to induce Epithelial Mesenchymal Transit (EMT) in the recipient cells. All of these mechanisms may contribute to EMT in normal bronchial epithelial cells [51] .
In a study of exosomes in lung cancer cell lines (A549, CRL 2066, CRL 2062, HTB 183, HTB 177) exosomes (PMV: platelet derived microvesicles) were found to contribute to metastatic spread. It has also been suggested that PMV may play an important role in angiogenesis in lung cancer [24] . It was possible to produce DEX vaccine in phase I study to test the safety, feasibility and efficacy of autologous Dendritic Cell (DC) -based Exosomes (DEX) loaded with MAGE tumor antigens in Non-Small Cell Lung Cancer (NSCLC) patients, and DEX treatment in patients with advanced NSCLC well-tolerated. In some patients, long-term disease stability and activation of immunologic effects have been observed [52] . The significant difference between total exosomal and exosomal miRNA levels between lung cancer and control individuals and the similarity between circulating exosomal miRNA and tumorinduced miRNA patterns suggests that exosome miRNA may be useful as a screening test for lung adenocarcinoma. The miRNAs in the exosome content are parallel to the miRNA expression profiles of the tumor cells [53] .
Conclusion
Success in treatment against multi-stage and complex diseases such as cancer can be achieved by understanding the interactions between different components within the tumor. Exosomes are components with large functions relative to their small size and play a major role in intracellular communication. Although exosomes were first described in the 1980's, studies on exosomes have been remarkably increasing over the last five years, especially after the discovery of functional mRNAs and miRNAs in exosomes. The exosomes are almost smart munchkins with the cargo contents they carry (mRNA, miRNA, protein, etc). Exosomes are components that have potency to use in diagnosis and treatment of many diseases not only in cancer. They characteristically carry the membrane and cytoplasmic properties of the cells they release. In addition, the availability of ultracentrifugation and isolation kits from all the fluid in the body can facilitate diagnosis for many diseases.
In addition, exosomes are an intensive research area with miRNA contents, and targeted inactivation of miRNAs does not only target tumor cells, may also be a new strategy to target the microenvironment. Due to the interesting and unusual features of exosomes, research studies on diagnosis and treatment are ongoing. Their origins differ from cell types and are obtainable from all the body fluids, an advantage for cancer-related studies. We are thinking that exosomes will be an important component not only for the formation, progression, diagnosis and treatment of cancer but also for the formation mechanism and recognition of many diseases.
